Spectral AI Adds Healthcare Services Leader and Population Health Expert Deepak Sadagopan to Board of Directors
2023年10月2日 - 9:00PM
Spectral AI, Inc. (Nasdaq: MDAI; MDAIW) (“Spectral AI” or
the “Company”), an artificial intelligence (AI) company
focused on medical diagnostics for faster and more accurate
treatment decisions in wound care, today announced the appointment
of Deepak Sadagopan, MHCDS, to its board of directors. A
high-impact healthcare executive with more than 25 years of senior
leadership experience with top Fortune-rated corporations and
aggressive startup environments, he brings to the board expertise
in healthcare technology and analytics along with a successful
track record in product launches. Currently, Mr. Sadagopan is the
Chief Operating Officer of Population Health at Providence St.
Joseph Health, one of the largest healthcare systems in the U.S.,
where he leads population health initiatives across the system to
transform care.
“Deepak brings a wealth of knowledge and
relevant experience to Spectral AI as we advance the DeepView®
System through late-stage development and launch,” said Wensheng
Fan, the Company’s CEO. “This is a transformational period for our
company. Deepak’s contributions will enable us to continue to
accelerate our work in bringing our technology to doctors and
patients in need. We welcome him to the board with great
enthusiasm.”
Mr. Sadagopan, said, “This company is dedicated
to using imaging technology and AI to bring faster and more
accurate wound management treatment decisions to doctors. The
DeepView® System has the potential to improve the lives of
countless individuals and strengthen public health system
preparedness in the US to respond to mass casualty incidents. I am
energized by this opportunity to help guide the Company as it
approaches the final development work needed to get the technology
on the market.”
Mr. Sadagopan has held leadership roles
with Quest Diagnostics, McKesson and Edifecs. Over the past eight
years, he has focused on working closely with payers and providers
on the use of technology to drive business decisions making the
transition from volume to value-based delivery models. He is a
faculty member at the School of Public Health at the University of
Washington, where he teaches courses in value-based care and
economics. Mr. Sadagopan earned his master’s degree in
healthcare delivery and economics from Dartmouth College and has a
master’s degree in engineering, specializing in data science, from
the University of Connecticut. He holds an undergraduate degree in
engineering from the University of Madras.
About Spectral AI
Spectral AI, Inc. is a Dallas-based predictive AI company
focused on medical diagnostics for faster and more accurate
treatment decisions in wound care, with initial applications
involving patients with burns and diabetic foot ulcers. The Company
is working to revolutionize the management of wound care by “Seeing
the Unknown®” with its DeepView® System. DeepView® is a
predictive diagnostic device that offers clinicians an objective
and immediate assessment of a wound’s healing potential prior to
treatment or other medical intervention. With algorithm-driven
results and a goal of substantially exceeding the current standard
of care in the future, DeepView® is expected to provide faster
and more accurate treatment insight towards value care by improving
patient outcomes and reducing healthcare costs. For more
information about DeepView®, visit www.spectral-ai.com.
Forward Looking StatementsCertain statements
made in this release are “forward looking statements” within the
meaning of the “safe harbor” provisions of the United States
Private Securities Litigation Reform Act of 1995, including
statements regarding the Company’s strategy, plans, objectives,
initiatives and financial outlook. When used in this press release,
the words “estimates,” “projected,” “expects,” “anticipates,”
“forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,”
“will,” “should,” “future,” “propose” and variations of these words
or similar expressions (or the negative versions of such words or
expressions) are intended to identify forward-looking
statements.
These forward-looking statements are not guarantees of future
performance, conditions or results, and involve a number of known
and unknown risks, uncertainties, assumptions and other important
factors, many of which are outside Company’s control, that could
cause actual results or outcomes to differ materially from those
discussed in the forward-looking statements. As such, readers are
cautioned not to place undue reliance on any forward-looking
statements.
Investors should carefully consider the foregoing factors and
the other risks and uncertainties described in the “Risk Factors”
sections of the Company’s filings with the SEC, including the
Registration Statement and the other documents filed by the
Company. These filings identify and address other important risks
and uncertainties that could cause actual events and results to
differ materially from those contained in the forward-looking
statements.
Contacts:Investors:The
Equity GroupDevin SullivanManaging
Directordsullivan@equityny.com
Conor RodriguezAnalystcrodriguez@equityny.com
Media:Russo PartnersDavid
SchullRusso Partners(858)
717-2310david.schull@russopartnersllc.com
Guillermo Ruiz, M.D., Ph.D.Russo Partners(646)
218-4604guillermo.ruiz@russopartnersllc.com
Spectral AI (NASDAQ:MDAI)
過去 株価チャート
から 5 2024 まで 6 2024
Spectral AI (NASDAQ:MDAI)
過去 株価チャート
から 6 2023 まで 6 2024